Antibody in the sera of 15B X 72 chickens was measured for reactivity to determinants of the envelope glycoprotein of endogenous and exogenous avian tumor viruses. The pattern of reactivity of animals infected with exogenous sarcoma virus served to operationally define a class of determinants present on the envelope glycoprotein of exogenous viruses and absent from that of the endogenous virus Rous-associated virus-0.
Two classes of antigenic determinants have previously been detected on the envelope glycoprotein (VGP) of avian tumor virus: type-specific determinants, which mediate virus neutralization and are cross-reactive among viruses of a particular subgroup (2, 5) , and group-specific determinants, which are common to all nondefective avian tumor viruses including the subgroup E endogenous virus Rous-associated virus-0 (RAV-0; 3, 6, 7). As measured with chickens bearing tumors induced by infection with exogenous (non-subgroup E) avian sarcoma virus, both classes of antigenic determinants were strongly immunogenic in a number of chick helper factor-negative [chf(-)] chickens that were tested (4) . In contrast, type-specific reactivity but little or no group-specific reactivity was detectable in tumor-bearing chf(+) chickens, which suggests that the synthesis of endogenous viral envelope-related glycoprotein affects the expression of immunity to the VGP of exogenous viruses.
The experiments described here were carried out to assess the immunogenicity of the VGP of exogenous avian sarcoma virus in chickens positive for RAV-0 production [V(+)]. The V(+) chickens used in this study were 15B x 72 chickens (1, 9) ; embryonated eggs were kindly provided by the Regional Poultry Research Laboratory, East Lansing, Mich. To ascertain whether all the chickens were V(+), cultures of fibroblasts were prepared from muscle biopsies obtained from a wing of each chicken at 2 weeks posthatch. To score for virus produced by the cultures at confluence, the culture media were assayed for sedimentable reverse transcriptase (8) . Of 24 chickens that were nominally 15B X 72 and examined by this assay, 22 were judged to be V(+) because the level of sedimentable enzyme activity was several hundredfold above background, which was defined with culture media from V(-) cells. This level of activity was comparable to that measured with a confluent culture of fibroblasts prepared from a 10-day-old 15B X 72 embryo that was shown by biological assay to produce RAV-0. Only the 22 chickens that scored as V(+) were used in further experiments.
At 4 weeks posthatch, several days after the collection of preinfection sera, eight of the V(+) chickens were infected by subcutaneous inoculation in the wing web with the Prague strain of Rous sarcoma virus, subgroup A (Pr-A), and seven of the chickens were infected with B,, virus, subgroup C [the term "infected" as applied to 15B3 x 72 chickens refers to those animals inoculated with exogenous avian sarcoma virus; all V(+) chickens are of course infected with RAV-0]. Tumor formation at the site of inoculation was visible 2 to 3 weeks later, and the tumors generally progressed for the course of the experiment. In addition, seven chickens were left uninfected and housed in the same room as the infected chickens. Serum samples from each chicken were obtained 2 weeks after the time of virus inoculation and at 2-week intervals thereafter. Although the majority of the infected chickens succumbed by 12 weeks postinfection, six infected animals survived past 12 weeks.
Antibody reactivity in the various sera to determinants of the VGP was then measured in indirect immunoprecipitation assays, using purified preparations of [3H]glucosamine-labeled viruses disrupted with Nonidet P-40 (4). Before these assays were carried out, labeled VGP in all the virus preparations was shown to be specifically precipitable, as described earlier (4), with sera from tumor-bearing chf(-), V(-) chickens, implying that the VGP test antigens were not denatured by the procedures of virus purifica-tion or glycoprotein solubilization. The results of the immunoprecipitation assays with sera of several of the 15B X 7, chickens are shown in Table 1 .
As measured with the viral test antigens of subgroups A, B, C, and D, increased levels of radioactivity, in comparison to levels obtained ' A 15-pl amount of chicken serum was reacted with 10,000 cpm of ['H]glucosamine-labeled virus in indirect immunoprecipitation assays carried out as described previouslyS (4 with preinfection sera, were detected in immune precipitates prepared with postinfection sera of the infected V(+) chickens. Electrophoresis on sodium dodecyl sulfate gels of a number of these immune precipitates indicated that greater than 80% of the radioactivity comigrated with viral glycoprotein (data not shown). In tests of these sera against the subgroup E VGP, a markedly reduced or negligible increase in precipitable radioactivity was detected relative to the increase measured with exogenous VGP. As shown in Table 2 for several of the longer-lived infected chickens, the absence of reactivity for the VGP of RAV-0 persisted up to 12 to 14 weeks postinfection, the maximum interval tested. Little or no increase in precipitable radioactivity was measured with sera of the uninfected V(+) chickens as tested against any of the virus preparations. Results qualitatively similar to those presented in Table 1 were obtained with the other 11 infected and 5 noninfected 15B x 7.2 chickens.
Weaker reactivity developed for the VGP of the subgroup D virus than for the VGP of viruses of the other exogenous subgroups, particularly A and C. Smith et al. (7) had noted earlier that determinants on the VGP of viruses of subgroups D and E are cross-reactive, and the weak reactivity for subgroup D VGP in the immunoprecipitation assays may reflect this cross-reactivity. In any case, the apparent differences in levels of reactivity for exogenous VGP point up the possibility that an individual determinant on the VGP of the exogenous virus used for infec- B-Pr-B; E-Bryan high-titer strain of Rous sarcoma virus (RAV-0).
'Animals died before collection of serum.
tion may be common to only a subset of the exogenous VGP test antigens. Virus neutralization assays were then carried out to measure type-specific reactivity in the sera. As quantitated by focus assay, the sera of the uninfected V(+) chickens did not neutralize viruses of subgroup A, B, C, D, or E. Postinfection sera of the infected V(+) chickens did not neutralize subgroup E virus and neutralized exogenous virus only of the same subgroup as that of the virus used for infection; with serum samples obtained 8 weeks postinfection, the titers for 90% neutralization of the same viruses as used for infection of the chickens were of the order of 1:50 (for B77 neutralization) and 1:200 (for Pr-A neutralization).
Our interpretation of the neutralization and immunoprecipitation assays is that antibody in the sera of infected 15B X 72 chickens recognizes non-neutralizing determinants that, at least collectively, are present on the VGP of several, if not all, exogenous viruses. The absence of these determinants from the VGP of RAV-0 serves to distinguish them from group-specific determinants. These determinants therefore fall into a classification category in which cross-reactivity of non-group-specific determinants spans two or more subgroups.
We would emphasize that the present data do not answer whether group-specific determinants are immunogenic in infected 15B X 72 chickens. It is possible that group-specific reactive antibody is in fact synthesized in these chickens and the nonreactivity in the immunoprecipitation assays reflects complexing to endogenous RAV-0. Alternatively, group-specific determinants on the endogenous RAV-0 may tolerize potentially reactive lymphocytes in 15B X 72 chickens. Because of the relatively high levels of endogenous RAV-0 production, B (bursa-derived) as well as T (thymus-derived) lymphocytes may be tolerized so that circumvention of tolerance is precluded.
